Award Miscellaneous

NHS National Framework for Aripiprazole prolonged release injection

Buyer: NHS England

DEADLINE: Awarded

This tender has been awarded.

REGION: London

Main delivery area

Description excerpt

VALUE

£32M

Estimated value

TYPE

Framework

Not specified

SME FIT

-----

No info

DURATION (est.)

-----

Not specified

Related Terms

Quick Actions

As a subscriber you can save this tender or set notifications for updates.

Save this

Remind me

View source

Geochart for 1 buyers and 3 suppliers

3 Suppliers

Description

Project title: NHS National Framework for Aripiprazole prolonged release injection commencing 1st February 2027 Offer reference number: CM/TNS/26/5741 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5741 Aripiprazole prolonged release injection Lot 1 CESW 01/02/2027 to 30/09/2027 (8 months) Lot 2 NWLN 01/02/2027 to 31/01/2029 (24 months) Lot 3 LSNE 01/02/2027 to 31/05/2028 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Award Detail

1	Otsuka Pharmaceuticals (Windsor) NHS National Framework for Aripiprazole prolonged release injection Reference: 1 Value: £32,140,000 [share] Awarded to group of suppliers.
2	Perennial Pharma (Hatfield) NHS National Framework for Aripiprazole prolonged release injection Reference: 1 Value: £32,140,000 [share] Awarded to group of suppliers.
3	Sun Pharma (Uxbridge) NHS National Framework for Aripiprazole prolonged release injection Reference: 1 Value: £32,140,000 [share] Awarded to group of suppliers.